Patients being treated with the drug should be advised to discontinue treatment and seek medical help immediately if any of the following symptoms occur:
- Severe rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (SJS)
- Red rash covered with small pus-filled bumps that can spread over the body, sometimes with a fever (AGEP)
- Rash that may blister, with spots that look like small targets (erythema multiforme)
All serious suspected adverse reactions associated with galantamine should be reported in accordance with the MHRA Yellow Card Scheme.